These five large-cap value dividend stocks look poised to provide some second-half gains with steady ultra-high-yield ...

The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...

The pound rose to USD1.3450 late on Friday afternoon in London, compared to USD1.3412 at the equities close on Thursday. The euro traded at USD1.1666, higher against USD1.1631. Against the yen, the ...

Pfizer Inc. grapples with downgraded Q3 earnings forecasts. Leerink Partners slashed their earnings prediction to $0.80 per ...

The FTSE 100 edged down on Friday on a mixed day for European equities despite new optimism about an end to the war between ...

Abbott Laboratories’ ABT Established Pharmaceuticals Division (“EPD”) operates solely in emerging geographies, with leading positions in many of the largest and fastest-growing pharmaceutical markets ...

Volatility: Blue chip stocks are usually less volatile than other stocks.

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more ...

Tokyo, Japan and Cambridge, UK, 8 August 2025 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the second ...

Recent health news highlights include Kenvue cutting its sales forecast amid strategic changes, Eli Lilly raising its profit ...

Pfizer Inc. (NYSE: PFE) delivered a stronger-than-anticipated second-quarter performance, beating analyst estimates and ...